The company develops autologous stem cell therapies for debilitating neurodegenerative diseases, such as amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease. It develops NurOwn technology for the propagation and differentiation of autologous mesenchymal stem cells into neurotrophic factor -secreting cells and their transplantation at or near the site of damage.
http://ift.tt/1KTrNqt
http://ift.tt/1KTrNqt
No comments:
Post a Comment